Eli Lilly has presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor agonist candidate brenipatide in substance use, psychiatric, and immunologic disorders—and ...

A 12-week pilot study found time-restricted eating was safe and feasible for people with early Huntington’s disease.

In his new book "Curved Air", Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in ...

Discovery could open up new avenues for studying diseases that affect the brainstem, such as spinal muscular atrophy and amyotrophic lateral sclerosis.

Researchers say that organoids have the potential to give researchers a more human-relevant view of disease and treatment response.

Study identified age-related HGG patient groups that demonstrated distinct molecular profiles and survival outcomes, and were ...

Sartorius and the Ireland-based National Institute for Bioprocessing Research and Training (NIBRT) are partnering to establish a training center for intensified and fully continuous bioprocessing in ...

The company has plans to launch an early access program this month to test-drive the second-generation of its AI platform.

Study supports translational relevance of mouse model to ADHD and indicates that targeting D2R dysfunction may represent a ...

Researchers at Virginia Tech have developed a prophylactic phage therapy approach to protecting against potential future ...

Cellares' collaboration will focus on the translation of GenomeFrontier’s manufacturing process to the Cell Shuttle.